See below for a summary of products, either in development or on the market, that incorporate Washington University IP. For more information on the product or the licensing partner, click on the links provided.
Therapeutics
| Product | Licensee |  Preclinical Phase IPhase II Phase III NDA Market |
|---|---|---|
| σ-2 Receptor Targeting | Accuronix Therapeutics |  |
| UTI O-Mannoside | Fimbrion Therapeutics, Inc. | |
| UTI C-Mannoside | Fimbrion Therapeutics, Inc. | |
| Factor-VIIa-CTP | Opko Biologics (Modigene) |  |
| hGH-CTP | Opko Biologics (Modigene) | |
| Long-Acting Oxyntomodulin | Opko Biologics (Modigene) | |
| ABBV-8E12 | C2N Diagnostics |  |
| Modified pyrazolopyrimidine (PP) Inhibitors | Turing | |
Device Products
| Product | Licensee | Preclinical Phase IPhase II Phase III NDA Market |
|---|---|---|
| Cerafix® Dura Substitute | Acera Surgical | |
| Inferior Nodal Extension Pacing | Cardialen, Inc. | |
| Atrial Unpinning Pulse Termination Therapy | Cardialen, Inc. | |
| Ventricular Unpinning Pulse Termination Therapy | Cardialen, Inc. | |
| Next-Gen Air Filtration | Applied Particle Technology | |
| Brain Computer Interface (BCI) Technology | Neurolutions | |
COMPUTING/Software
| Product | Licensee | Preclinical Phase IPhase II Phase III NDA Market |
|---|---|---|
| VarScan | Appistry |  |
| Customized Hearing Healthcare | clEAR, LLC | |
| Exegy Ticker Plant | Exegy | |
| Exegy Trading Application Platform (TAP) | Exegy | |
| Exegy Market Data System | Exegy | |
| Exegy Data Tone | Exegy | |
| 2-1-1 Counts | Health Communication Impact, LLC | |
| Vortex | Velocidata | |
| Raptor | Velocidata | |
Diagnostics
| Product | Licensee | Preclinical Phase IPhase II Phase III NDA Market |
|---|---|---|
| SILK-Aβ® (Total) | C2N Diagnostics, LLC | |
| SILK-Aβ® (Isoforms) | C2N Diagnostics, LLC | |
| SILK-Aβ® SPOT (Companion Dx Test) | C2N Diagnostics, LLC | |
| SILK-ApoE™ (Isoforms) | C2N Diagnostics, LLC | |
| SILK-sAPP™ (sAPPα and β) | C2N Diagnostics, LLC | |
| SISAQ-Aβ™ (Aβ Total and Isoforms) | C2N Diagnostics, LLC | |
| SISAQ™-Multi-Analyte Dementia Panel | C2N Diagnostics, LLC | |
| SILK-SOD1™ | C2N Diagnostics, LLC | |
| Gene detecting Cancer in Melanoma Patients | Castle BioSciences Inc. | |
| Myoglobin | Siemens (fmk Dade Behring Inc.) | |
| Elvis® | Diagnostic Hybrids (Quidel Corporation) | |
| Cancer Antigens Targeting TIP1 and GRP78 | Medical Guidance Systems LLC | |
Consumer Products
| Product | Licensee | Preclinical Phase IPhase II Phase III NDA Market |
|---|---|---|
| Niagen® | ChromaDex, Inc. | |